Teladoc Health, Inc.TDOCNYSE
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank54
3Y CAGR+351.1%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+351.1%/yr
vs -86.5%/yr prior
Acceleration
+437.6pp
Accelerating
Percentile
P54
Within normal range
vs 3Y Ago
91.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 25.28% |
| Q3 2025 | -24.64% |
| Q2 2025 | 675.54% |
| Q1 2025 | -127.85% |
| Q4 2024 | -28.81% |
| Q3 2024 | -8.92% |
| Q2 2024 | 1016.60% |
| Q1 2024 | -93.96% |
| Q4 2023 | 89.36% |
| Q3 2023 | -31.55% |
| Q2 2023 | 819.84% |
| Q1 2023 | -81.82% |
| Q4 2022 | 0.28% |
| Q3 2022 | -34.18% |
| Q2 2022 | 352.18% |
| Q1 2022 | -144.42% |
| Q4 2021 | 6.50% |
| Q3 2021 | 50.99% |
| Q2 2021 | 347.89% |
| Q1 2021 | 82.65% |
| Q4 2020 | -606.98% |
| Q3 2020 | -24.65% |
| Q2 2020 | 517.30% |
| Q1 2020 | -149.45% |
| Q4 2019 | 44.27% |
| Q3 2019 | 183.87% |
| Q2 2019 | 137.61% |
| Q1 2019 | -2068.25% |
| Q4 2018 | -105.45% |
| Q3 2018 | 234.43% |
| Q2 2018 | 59.59% |
| Q1 2018 | -60.65% |
| Q4 2017 | 32.19% |
| Q3 2017 | -267.07% |
| Q2 2017 | 71.94% |
| Q1 2017 | -39.97% |
| Q4 2016 | 38.43% |
| Q3 2016 | -23.07% |
| Q2 2016 | 29.62% |
| Q1 2016 | -27.38% |